Navigation Links
Medication Adherence Technology Combines with Patient Outreach Program to Yield Healthier Populations and Reduce Healthcare Costs
Date:10/20/2009

ow the regimen. "The primary complaint we hear from the market is that technology or services operating independently does not achieve the required medication adherence," said William Bilyak, Director of Operations, PresentCare. "Our unique integration of state of the art technology and services will help to obtain better patient outcomes."

PresentCare works in conjunction with existing disease management (DM), case management (CM), discharge planning, home health, commercial, medicaid and medicare programs to enhance services and improve program outcomes. PresentCare integrates the technologies and performs the initial outreach to minimize the cost of improved medication adherence while maximizing the focus of existing programs.

AdherencePlus is a valuable tool for care management. It features a unique electronic pill box that is connected to a full-service monitoring system, operational 24/7. The pill box transmits alerts to the PresentCare coordination staff when medications are missed or taken at the wrong time. For the mobile population, alerts sent to the patient can be customized to include phone calls, pages, text messages, emails, and/or Interactive Voice Response (IVR). The level of outreach is structured according to the degree of the alert pre-selected by the care team, patient and caregiver. Based on the selected responses, a live outreach call may be made. This one-on-one attention supports and motivates the patient, resulting in healthier outcomes. Linking the technology and human service allows PresentCare to provide a full service medication adherence program. Purely technology based organizations do not provide the wrap around services such as initial and ongoing medication reconciliation, troubleshooting technology related issues, triaging symptomatic calls and live education that is required to support medication adherence.

As part of the process, PresentCare provides robust outcome reporting to the p
'/>"/>

SOURCE PresentCare Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Medication Telemonitoring Improves Compliance and Behavior in NIH Study
2. New Pleio Medication Adherence Service Increases Prescription Refills Up To 53%
3. Drug Interaction Tool Offered Free in Response to Increasing At-Home Deaths From Medication Errors
4. Family Medicine Cabinet: Free, New On-Line Tool Helps Track Your Medication Safety
5. Cephalon Launches National Consumer Awareness Initiative on Appropriate Use of Prescription Opioid Medications
6. North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes
7. Prominent Physician Achieves Success Using Topical Sinus Medications via Pulsitile Irrigation
8. Pharmacy Students Taught Improved Medication Adherence and Holistic Health Services Through Program Incorporating InforMedixs Med-eXpert(TM) System
9. InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions
10. Artromick Aligns with McKesson to Enhance Medication Safety at the Patients Bedside
11. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015 Research and Markets ( http://www.researchandmarkets.com/research/p2ddnr/global_market ... Report of Trypsin" report to their offering. , ... at providing comprehensive data on Trypsin globally and regionally ( ... North America , Latin America ... to Trypsin This report focuses on three primary ...
(Date:2/27/2015)... Bionomics Limited (ASX:BNO, ADR:BMICY) is to present ... in patients with metastatic renal cancer at the ASCO ... . The data will be presented by Dr. ... Cancer Center in California in ... identifies Ferritin and IL-8 as two baseline biomarkers that ...
(Date:2/27/2015)... Cytokinetics, Incorporated (Nasdaq: CYTK) announced today ... patients and health care advocates in the United States ... Rare Disease Day is dedicated to elevating public ... special challenges faced by patients with rare diseases and ... to stand alongside patients and caregivers representing the rare ...
(Date:2/26/2015)... YORK , Feb. 26, 2015 S&P ... Factual Stock Report coverage on MabVax Therapeutics Holdings ... (MBVX) is a clinical stage biotechnology company focused on ... unmet medical needs in the treatment of cancer. MabVax ... based on the protective immune responses generated by patients ...
Breaking Biology Technology:Global Market Report of Trypsin 2014-2018 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5
... , , , , Multiporator , , , , ... Transfection Protocol , Protocol No. 4308 915.026 11/2001 , ... , , , , , ... line), , , ...
... , , , , , Multiporator / Electroporator 2510 , , , ... Transformation Protocol , Protocol No. 4308 915.529 01/2002 , ... , , , , , ... , Cell type , ...
... , , , , , , , ... 4308 915.047 11/2001 , , , , , , ... Organism , Neurospora crassa, , ... Filamentous fungus, protoplasts, , , ...
Cached Biology Technology:Sp20-Ag14 2Sp20-Ag14 3Pseudomonas putida 2Neurospora crassa 2
(Date:2/23/2015)... , Feb. 23, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62114357 for DISTRIBUTED VOICE DIRECTED ... NXT-ID introduces a new groundbreaking payment method. Payment accounts ... account may only be accessed if both the speech ...
(Date:2/12/2015)... MINNETONKA, Minn. , Feb. 12, 2015 /PRNewswire/ ... technology company specializing in clinical study management systems, ... Partner Program , further distinguishing iMedNet ... for Clinical Research Organizations (CROs) and healthcare consultants.  ... sales support, prospective customer referrals and numerous co-marketing ...
(Date:2/9/2015)... 9, 2015  Lintec of America recently announced an ... nanotube (CNT) macrostructures, including sheets, yarns and ribbons, developed ... Leveraging the vast industrial resources of the global ... , Lintec of America is forming the Nano-Science and ... , focusing on scaling up the manufacturing and commercialization ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... to DNA damage that occurs when metal ions in the body such as iron and copper ... and that occur naturally in fruits, vegetables, green tea, garlic and onions can be effective at ... ... ...
... Maria Divina Deato and Robert Tjian (HHMI, UC Berkeley) ... promoter complex directs cell-type specific differentiation during myogenesis. The ... of terminal cell differentiation, and will be published online ... www.genesdev.org . For nearly 30 years, we have ...
... from the University of Aberdeen is leading a team of ... in the deepest oceans, and contribute to the global Census ... Ocean at various depths of 800 to 3,500 metres, a ... expedition which has surfaced a wealth of new information and ...
Cached Biology News:'New continent' and species discovered in Atlantic study 2'New continent' and species discovered in Atlantic study 3
...
...
with GlutaMAXIL-glutamine...
... PURIFIED GOAT ANTI-MOUSE IgG+IgA+IgM ... conjugated with highly purified ... The antibody has been ... rat, fetal bovine, horse, ...
Biology Products: